No datasets match
- 1.curatedBladderData::GSE13507_esetPredictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer.
- 2.curatedBladderData::GSE1827_esetBladder cancer outcome and subtype classification by gene expression.
- 3.curatedBladderData::GSE19915.GPL3883_esetCombined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome.
- 4.curatedBladderData::GSE19915.GPL5186_esetCombined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome.
- 5.curatedBladderData::GSE31189_esetA candidate molecular biomarker panel for the detection of bladder cancer.
- 6.curatedBladderData::GSE31684_esetCombination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer.
- 7.curatedBladderData::GSE32894_esetA molecular taxonomy for urothelial carcinoma.
- 8.curatedBladderData::GSE37317_esetTranscriptional signatures of Ral GTPase are associated with aggressive clinicopathologic characteristics in human cancer.
- 9.curatedBladderData::GSE5287_esetEmmprin and survivin predict response and survival following cisplatin-containing chemotherapy in patients with advanced bladder cancer.
- 10.curatedBladderData::GSE89_esetIdentifying distinct classes of bladder carcinoma using microarrays.
- 11.curatedBladderData::PMID17099711.GPL8300_esetRegional copy number-independent deregulation of transcription in cancer.
- 12.curatedBladderData::PMID17099711.GPL91_esetRegional copy number-independent deregulation of transcription in cancer.
- 13.PureCN::centromeresA list of data.frames containing centromere positions.
- 14.PureCN::purecn.DNAcopy.bdryDNAcopy boundary data
- 15.PureCN::purecn.example.outputExample output